By Lucy Parkinson, Senior Research Manager, LSN
The first Redefining Early Stage Investments (RESI) Conference took place on September 16, 2013, and two years later, following highly successful events in San Francisco and Houston, we return to Boston for the sixth RESI Conference. With new and returning sponsors including Johnson & Johnson Innovation JLABS, Charles River Laboratories, McDermott Will & Emory, and Wuxi AppTec, we expect this event to be the largest RESI so far, with more content and more meetings than ever.
The RESI Conference Series was founded with the goal of creating meetings based on a common fit. Our experience shows that starting with fit, and then finding a targeted alignment between entrepreneurs and investors, leads to compelling conversations; RESI’s mission is to provide a venue for those conversations to begin and develop. By connecting early stage life science fundraising executives with the right investors, RESI is where qualified fundraising relationships arise.
LSN’s CEO, Dennis Ford, says, “We want to inundate the attendees of RESI Boston with more amazing opportunities than they can handle, including one-on-one investor meetings, firsthand information from RESI’s early stage investor panels, and tactical guidance from fundraising workshops—because if we’re doing that, we’re doing our job. We want to provide a huge amount of relevant content to everyone, on one day. RESI’s goal is to give the fundraising CEOs and scientist entrepreneurs in this early stage investment world as much value as possible.”
RESI Boston offers entrepreneurs the opportunity to schedule up to 16 meetings with investors through the RESI Partnering Platform; and in addition to these face-to-face meetings, 20+ panels and workshops focused on various aspects of fundraising and investment will provide platforms for investors and industry veterans to share valuable insights with fundraising entrepreneurs.
If you’d like to be part of the largest RESI ever, you can register before 7/31/2015 at the Early Bird Rate here.